Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 11.85%84.31M | ---- | -38.46%75.38M | ---- | -38.76%122.48M | ---- | -34.17%200M | ---- | 21.96%303.83M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 23.21%-8.22M | ---- | 21.96%-10.71M | ---- | 8.27%-13.72M | ---- | -20.45%-14.96M | ---- | -11.21%-12.42M |
| Interest expense - adjustment | ---- | 30.61%23.17M | ---- | 57.28%17.74M | ---- | -47.99%11.28M | ---- | -30.80%21.68M | ---- | -31.67%31.34M |
| Impairment and provisions: | ---- | -222.51%-4.28M | ---- | 138.72%3.5M | ---- | -530.22%-9.03M | ---- | -130.34%-1.43M | ---- | 153.94%4.72M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | 51.57%-3.31M | ---- | -102.76%-6.83M | ---- | ---3.37M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -182.25%-6.63M | ---- | 266.54%8.06M | ---- | 2.75%-4.84M | ---- | -228.72%-4.98M | ---- | 128.79%3.87M |
| -Impairment of trade receivables (reversal) | ---- | 287.14%2.34M | ---- | -147.46%-1.25M | ---- | -61.83%2.64M | ---- | 705.48%6.91M | ---- | 136.23%858K |
| Asset sale loss (gain): | ---- | -19.95%5.27M | ---- | 9.69%6.58M | ---- | 112.51%6M | ---- | -41,075.21%-47.94M | ---- | -98.74%117K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,878.43%-9.53M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -19.95%5.27M | ---- | 9.69%6.58M | ---- | 192.72%6M | ---- | -167.04%-6.47M | ---- | 8.11%9.65M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---41.47M | ---- | ---- |
| Depreciation and amortization: | ---- | 29.87%179.81M | ---- | -5.90%138.45M | ---- | -10.30%147.14M | ---- | -2.37%164.03M | ---- | 1.59%168.01M |
| -Depreciation | ---- | 31.81%171.7M | ---- | -3.38%130.26M | ---- | -13.88%134.82M | ---- | --156.56M | ---- | ---- |
| -Other depreciation and amortization | ---- | -0.96%8.11M | ---- | -33.46%8.19M | ---- | 64.69%12.31M | ---- | -36.62%7.48M | ---- | --11.8M |
| Exchange Loss (gain) | ---- | -4.96%-3.3M | ---- | 88.83%-3.14M | ---- | -483.66%-28.13M | ---- | -30.81%7.33M | ---- | 8.25%10.6M |
| Special items | ---- | 5.25%9M | ---- | -45.89%8.55M | ---- | -31.63%15.8M | ---- | -61.45%23.11M | ---- | 9,776.77%59.95M |
| Operating profit before the change of operating capital | ---- | 20.90%285.75M | ---- | -6.14%236.34M | ---- | -28.43%251.81M | ---- | -37.86%351.83M | ---- | 23.05%566.15M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -140.00%-54.44M | ---- | 334.56%136.11M | ---- | -26,157.01%-58.03M | ---- | 98.02%-221K | ---- | 84.92%-11.18M |
| Accounts receivable (increase)decrease | ---- | 76.09%40.6M | ---- | -69.66%23.06M | ---- | 178.15%76M | ---- | -230.83%-97.26M | ---- | 2.79%-29.4M |
| Accounts payable increase (decrease) | ---- | 45.29%34.21M | ---- | -77.91%23.55M | ---- | 965.54%106.6M | ---- | -123.77%-12.32M | ---- | -39.77%51.81M |
| Special items for working capital changes | ---- | 2,494.97%11.86M | ---- | 101.97%457K | ---- | -244.45%-23.18M | ---- | 153.20%16.05M | ---- | 115.18%6.34M |
| Cash from business operations | -46.96%67.5M | -24.20%317.98M | -25.57%127.26M | 18.77%419.51M | 94.05%170.98M | 36.86%353.2M | 74.92%88.11M | -55.79%258.08M | -59.10%50.37M | 45.93%583.72M |
| Other taxs | -86.68%-6.28M | 3.57%-11.82M | 47.25%-3.36M | -1.87%-12.26M | 13.75%-6.38M | 44.18%-12.04M | 53.18%-7.39M | 59.76%-21.56M | 39.39%-15.79M | -102.07%-53.59M |
| Net cash from operations | -50.59%61.22M | -24.82%306.15M | -24.73%123.9M | 19.37%407.25M | 103.92%164.6M | 44.24%341.16M | 133.39%80.72M | -55.38%236.52M | -64.39%34.59M | 41.94%530.13M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -23.21%8.22M | ---- | -21.96%10.71M | ---- | -8.27%13.72M | ---- | 20.45%14.96M | ---- | 11.21%12.42M |
| Decrease in deposits (increase) | ---- | 99.55%-11K | ---- | ---2.45M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | 184.11%18.66M | ---- | -52.27%6.57M | ---- | -35.90%13.76M | ---- | 204.96%21.47M | ---- | -68.38%7.04M |
| Purchase of fixed assets | ---- | 32.43%-369.13M | ---- | -45.59%-546.28M | ---- | -81.74%-375.21M | ---- | -35.13%-206.46M | ---- | -27.87%-152.78M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -18.44%25.33M | ---- | 176.46%31.05M |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6M |
| Other items in the investment business | 72.51%-57.58M | ---- | 17.89%-209.49M | ---- | -125.31%-255.11M | ---- | -107.67%-113.23M | ---- | 1.06%-54.52M | ---- |
| Net cash from investment operations | 72.51%-57.58M | 35.60%-342.26M | 17.89%-209.49M | -52.83%-531.45M | -125.31%-255.11M | -140.30%-347.73M | -107.67%-113.23M | -33.65%-144.7M | 1.06%-54.52M | -44.72%-108.27M |
| Net cash before financing | 104.26%3.64M | 70.93%-36.1M | 5.44%-85.59M | -1,792.11%-124.2M | -178.43%-90.51M | -107.15%-6.56M | -63.05%-32.51M | -78.24%91.82M | -147.46%-19.94M | 41.25%421.86M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -47.89%746.14M | ---- | 104.90%1.43B | ---- | -28.76%698.78M | ---- | 15.63%980.81M | ---- | 12.84%848.25M |
| Refund | ---- | 44.57%-708.98M | ---- | -77.77%-1.28B | ---- | 28.53%-719.42M | ---- | -10.09%-1.01B | ---- | 9.25%-914.39M |
| Interest paid - financing | ---- | -39.07%-23.47M | ---- | -49.66%-16.88M | ---- | 47.99%-11.28M | ---- | 31.30%-21.68M | ---- | 31.30%-31.57M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -6.14%-44.16M | ---- | -28.29%-41.61M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---5.03M | ---- | ---- | ---- | 1,842.56%6.8M |
| Other items of the financing business | -217.10%-73.4M | -123.00%-32.54M | -28.30%62.68M | 68.86%-14.59M | 1,291.71%87.41M | ---46.86M | -90.67%6.28M | ---- | -61.58%67.32M | ---- |
| Net cash from financing operations | -217.10%-73.4M | -117.95%-21.29M | -28.30%62.68M | 235.21%118.6M | 1,291.71%87.41M | 13.07%-87.72M | -90.67%6.28M | 28.78%-100.9M | -61.58%67.32M | 58.38%-141.68M |
| Effect of rate | -179.49%-62K | -21.92%203K | -84.46%78K | -82.66%260K | -2.52%502K | -46.02%1.5M | 375.40%515K | 114.68%2.78M | -108.24%-187K | -703.45%-18.91M |
| Net Cash | -204.44%-69.75M | -926.03%-57.4M | -639.34%-22.91M | 94.07%-5.59M | 88.18%-3.1M | -937.46%-94.28M | -155.35%-26.23M | -103.24%-9.09M | -78.19%47.38M | 771.04%280.18M |
| Begining period cash | -10.80%472.21M | -1.00%526.94M | -0.54%529.39M | -14.84%532.27M | -14.84%532.27M | -1.00%625.06M | -1.00%625.06M | 70.59%631.37M | 70.59%631.37M | -9.45%370.1M |
| Cash at the end | -20.56%402.39M | -10.85%469.75M | -4.37%506.56M | -1.00%526.94M | -11.62%529.68M | -14.84%532.27M | -11.67%599.35M | -1.00%625.06M | 15.09%678.57M | 70.59%631.37M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | PwC accounting firm | -- | PwC accounting firm | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.